Prothena (NASDAQ:PRTA) used its fourth-quarter and full-year 2025 results call to highlight partner-driven clinical momentum, updates from its wholly owned preclinical portfolio, and a sharper cash ...
Good afternoon, and thank you for joining Workiva Inc.'s Q4 2025 Conference Call. During today's call, we will review our fourth quarter and full year 2025 results and discuss our guidance for the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results